- €1.98bn
- €3.41bn
- €6.62bn
- 48
- 95
- 60
- 80
C2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,739 | 3,432 | 4,234 | 5,924 | 6,619 |
Cost of Revenue | |||||
Gross Profit | 912 | 953 | 965 | 706 | 1,166 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,574 | 3,223 | 3,704 | 5,889 | 5,556 |
Operating Profit | 165 | 209 | 530 | 34.5 | 1,063 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 112 | 161 | 489 | -0.77 | 1,022 |
Provision for Income Taxes | |||||
Net Income After Taxes | 76.3 | 114 | 345 | 10.6 | 753 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 46 | 93.9 | 199 | -292 | 1,045 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 46 | 93.9 | 199 | -292 | 1,045 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.784 | 1.57 | 3.07 | -4.26 | 14.5 |
Dividends per Share |